Skip to main content
OpenTrials

Clinical trial condition

Neurodegenerative Diseases

Explore clinical trials studying Neurodegenerative Diseases. Study availability and eligibility vary by location and protocol.

9,090 public trials 1,779 recruiting studies
Refine in advanced search Browse all conditions

Neurodegenerative Diseases trial results

Active, not recruiting

Observational Study on Determinants of Dementia After Stroke

NCT01334749

Conditions
Alzheimer Disease, Arterial Occlusive Diseases, Arteriosclerosis, +23 more
Locations
  • DZNE/Munich-Interdisciplinary Stroke Center Munich, Klinikum der Universität München, Campus Großhadern Munich, Bavaria, Germany
  • DZNE/Berlin - Neuroscience Research Center - Campus Mitte Charité Berlin, Germany
  • DZNE/Bonn - Klinik und Poliklinik für Neurologie, Universitätsklinikum Bonn Bonn, Germany
  • DZNE/Göttingen - University Medical Center Göttingen Göttingen, Germany
View Trial Details
Active, not recruiting

Remote Optimization, Adjustment and Measurement for Deep Brain Stimulation

NCT05269862

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations
  • University of Arizona Health Sciences Center Tucson, Arizona, United States
  • University of California at Davis Sacramento, California, United States
  • University of Miami Hospital Miami, Florida, United States
  • Rush University Medical Center Chicago, Illinois, United States
View all 18 locations
View Trial Details
Active, not recruiting

NYX-458 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Parkinson's Disease or Lewy Body Dementia (Cognition, Memory, Attention, Thinking)

NCT04148391

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +14 more
Locations
  • Aptinyx Clinical Site Scottsdale, Arizona, United States
  • Aptinyx Clinical Site Fresno, California, United States
  • Aptinyx Clinical Site Simi Valley, California, United States
  • Aptinyx Clinical Site Boca Raton, Florida, United States
View all 26 locations
View Trial Details
Active, not recruiting

A Study to Evaluate Efficacy, Safety, Tolerability and Exposure After a Repeat-dose of Sepofarsen (QR-110) in LCA10 (ILLUMINATE)

NCT03913143

Conditions
Blindness, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +26 more
Locations
  • University of Iowa Iowa City, Iowa, United States
  • Universitair Ziekenhuis Gent (UZ) Ghent, Belgium
  • INRET Clínica/ Santa Casa de Misericórdia de Belo Horizonte Belo Horizonte, Minas Gerais, Brazil
  • Federal University of São Paulo - Hospital São Paulo (UNIFESP-HSP) São Paulo, Brazil
View all 14 locations
View Trial Details

Related conditions